01235nas a2200325 4500000000100000008004100001260001600042653002600058653001900084653003000103653001400133653001100147653001800158653002300176653001200199653003200211653004500243653001600288653001200304653003000316653002400346653001800370653002800388100001700416245007000433300002000503490000700523520036500530022001400895 1984 d c1984 Feb 0110aAntitubercular Agents10aDermatomycoses10aDrug Therapy, Combination10aGranuloma10aHumans10aLeishmaniasis10aLeprostatic Agents10aleprosy10aMicrobial Sensitivity Tests10aMycobacterium Infections, Nontuberculous10aPenicillins10aScabies10aSkin Diseases, Infectious10aSyphilis, Cutaneous10aToxoplasmosis10aTuberculosis, Cutaneous1 aQadripur S A00a[Current status of the therapy of granulomatous skin infections]. a160, 163-4, 1710 v593 a

We report on granulomatous infections of the skin, as well as the current state of therapeutics. Cutaneous tuberculosis and presently desired therapeutic regiments are treated in detail. Diseases regarded as eradicated in Germany, such as brucellosis and listeriosis, do still occur. Their recognition and cure are discussed from a modern point of view.

 a0301-0481